JP2011144201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011144201A5 JP2011144201A5 JP2011093677A JP2011093677A JP2011144201A5 JP 2011144201 A5 JP2011144201 A5 JP 2011144201A5 JP 2011093677 A JP2011093677 A JP 2011093677A JP 2011093677 A JP2011093677 A JP 2011093677A JP 2011144201 A5 JP2011144201 A5 JP 2011144201A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- use according
- respiratory
- asthma
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 7
- 208000023504 respiratory system disease Diseases 0.000 claims 4
- 108090000467 Interferon-beta Proteins 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 241000709661 Enterovirus Species 0.000 claims 2
- 102100026720 Interferon beta Human genes 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 102000003996 Interferon-beta Human genes 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 230000005713 exacerbation Effects 0.000 claims 1
- 229960001388 interferon-beta Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0405634.7A GB0405634D0 (en) | 2004-03-12 | 2004-03-12 | Anti-virus therapy for respiratory diseases |
| GB0405634.7 | 2004-03-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007502414A Division JP4807526B2 (ja) | 2004-03-12 | 2005-03-07 | 呼吸器疾患の抗ウイルス療法のためのインターフェロン−β |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011144201A JP2011144201A (ja) | 2011-07-28 |
| JP2011144201A5 true JP2011144201A5 (cg-RX-API-DMAC7.html) | 2012-10-18 |
Family
ID=32117582
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007502414A Expired - Fee Related JP4807526B2 (ja) | 2004-03-12 | 2005-03-07 | 呼吸器疾患の抗ウイルス療法のためのインターフェロン−β |
| JP2011093677A Pending JP2011144201A (ja) | 2004-03-12 | 2011-04-20 | 呼吸器疾患の抗ウイルス療法のためのインターフェロン−β |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007502414A Expired - Fee Related JP4807526B2 (ja) | 2004-03-12 | 2005-03-07 | 呼吸器疾患の抗ウイルス療法のためのインターフェロン−β |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US7569216B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1734987B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4807526B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE466591T1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2787978A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602005021078D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1734987T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2343732T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0405634D0 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1734987T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1734987E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005087253A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
| US8318423B2 (en) * | 2004-07-06 | 2012-11-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting rhinoviruses |
| EP1922081B1 (en) * | 2005-09-09 | 2012-08-15 | Imperial Innovations Limited | Interferon lambda therapy for treatment of respiratory diseases |
| AU2005336519B2 (en) * | 2005-09-20 | 2012-05-10 | New York University | Method of treating pulmonary disease with interferons |
| DE102006022877B4 (de) | 2006-05-15 | 2009-01-29 | Sartorius Stedim Biotech Gmbh | Verfahren zur Bestimmung der Viabilität von Zellen in Zellkulturen |
| US7871603B2 (en) | 2007-05-18 | 2011-01-18 | Synairgen Research Limited | Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| GB0713402D0 (en) * | 2007-07-11 | 2007-08-22 | Cardiff & Vale Nhs Trust | A method of diagnosing a condition using a neural network |
| BRPI0819932A2 (pt) * | 2007-12-13 | 2019-07-30 | Glaxo Group Ltd | composição, uso de uma composição, dispositivo nebulizador, inalador ou intranasal, processos para produzir uma composição farmacêutica e uma composição polipeptídica, e, uso de um tampão fisiologicamente aceitável. |
| AU2009344851A1 (en) * | 2008-12-19 | 2011-06-23 | The Regents Of The University Of California | Use of epidermal growth factor inhibitors in the treatment of viral infection |
| EP2506759A4 (en) | 2009-12-02 | 2015-05-20 | Neetour Medical Ltd | SURVEILLANCE BASED ON HEMODYNAMIA AND ASSESSMENT OF RESPIRATORY DISEASES |
| DK2544705T3 (en) * | 2010-03-12 | 2016-09-19 | Synairgen Res Ltd | INTERFERON BETA TO USE IN THE LOWER AIR TRANSMISSION CAUSED BY INFLUENZA |
| PL3669892T3 (pl) | 2010-09-22 | 2024-10-07 | Ena Respiratory Pty Ltd | Kompozycja do zastosowania w metodzie immunostymulacyjnej |
| JP6730926B2 (ja) | 2014-01-08 | 2020-07-29 | プロージット ソウル バイオテクノロジー （ベイジン） カンパニー リミテッド | 融合ポリペプチドおよび使用方法 |
| JP7317796B2 (ja) * | 2017-07-24 | 2023-07-31 | ノババックス，インコーポレイテッド | 呼吸器疾患を治療するための方法および組成物 |
| FI3728289T3 (fi) | 2017-12-21 | 2025-11-11 | Axelia Oncology Pty Ltd | Optimoidut yhdisteet |
| WO2020168033A2 (en) * | 2019-02-13 | 2020-08-20 | University Of Florida Research Foundation, Inc. | Targeting lung-resident tnfr2+ cdc2 (r2d2) subpopulation to treat asthma |
| KR20220050873A (ko) | 2019-06-26 | 2022-04-25 | 악셀리아 온콜로지 피티와이 리미티드 | 신규한 분자 |
| US20230338475A1 (en) | 2020-07-20 | 2023-10-26 | Synairgen Research Limited | USE OF INHALED INTERFERON-BETA TO IMPROVE OUTCOME IN SARS-CoV-2 INFECTED PATIENTS |
| GB202014114D0 (en) * | 2020-09-08 | 2020-10-21 | Synairgen Res Ltd | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid |
| DK4240396T5 (da) * | 2020-11-04 | 2025-04-07 | Ethris Gmbh | Ifn-lambda-mrna til behandling af virusinfektioner |
| US20250281576A1 (en) * | 2021-01-13 | 2025-09-11 | Abion Inc. | Prophylactic administration method against respiratory virus, comprising administering interferon-beta to potential respiratory virus-infected subject |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596260B1 (en) * | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
| ES2245780T3 (es) * | 1994-05-18 | 2006-01-16 | Nektar Therapeutics | Metodos y composiciones para la formulacion de interferones como un polvo seco. |
| US6030609A (en) * | 1995-05-19 | 2000-02-29 | Case Western Reserve University | Method and composition for treating paramyxovirus |
| US20010031253A1 (en) * | 1996-07-24 | 2001-10-18 | Gruenberg Micheal L. | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| AU780270B2 (en) * | 2000-02-23 | 2005-03-10 | Association Francaise Contre Les Myopathies | Treatment of immune diseases |
| GB2362884A (en) | 2000-05-30 | 2001-12-05 | Isis Innovation | Extended duration of airway gene therapy |
| EP1334128A2 (en) | 2000-11-02 | 2003-08-13 | Maxygen Aps | New multimeric interferon beta polypeptides |
| WO2002072019A2 (en) * | 2001-03-13 | 2002-09-19 | Vical Incorporated | Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
| AU2003215136A1 (en) | 2002-02-08 | 2003-09-02 | University Of Medicine And Dentistry Of New Jersey | Ifn-a/b-independent mechanism of antiviral protection |
| US20040037809A1 (en) * | 2002-06-28 | 2004-02-26 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of interferon beta |
| WO2004037995A2 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| US7157559B2 (en) | 2003-08-07 | 2007-01-02 | Zymogenetics, Inc. | Homogeneous preparations of IL-28 and IL-29 |
| GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
| WO2005097165A2 (en) | 2004-04-02 | 2005-10-20 | Zymogenetics, Inc. | Il-28 and il-29 cysteine mutants for treating viral infection |
-
2004
- 2004-03-12 GB GBGB0405634.7A patent/GB0405634D0/en not_active Ceased
-
2005
- 2005-03-07 WO PCT/GB2005/050031 patent/WO2005087253A2/en not_active Ceased
- 2005-03-07 CA CA2787978A patent/CA2787978A1/en not_active Abandoned
- 2005-03-07 EP EP05708482A patent/EP1734987B1/en not_active Expired - Lifetime
- 2005-03-07 EP EP10161661A patent/EP2206512A3/en not_active Withdrawn
- 2005-03-07 PL PL05708482T patent/PL1734987T3/pl unknown
- 2005-03-07 DK DK05708482.4T patent/DK1734987T3/da active
- 2005-03-07 AT AT05708482T patent/ATE466591T1/de active
- 2005-03-07 JP JP2007502414A patent/JP4807526B2/ja not_active Expired - Fee Related
- 2005-03-07 PT PT05708482T patent/PT1734987E/pt unknown
- 2005-03-07 ES ES05708482T patent/ES2343732T3/es not_active Expired - Lifetime
- 2005-03-07 DE DE602005021078T patent/DE602005021078D1/de active Active
- 2005-03-07 CA CA2558212A patent/CA2558212C/en not_active Expired - Lifetime
-
2006
- 2006-09-08 US US11/517,763 patent/US7569216B2/en not_active Expired - Lifetime
-
2009
- 2009-06-18 US US12/487,563 patent/US8273342B2/en not_active Expired - Fee Related
-
2011
- 2011-04-20 JP JP2011093677A patent/JP2011144201A/ja active Pending
-
2012
- 2012-08-16 US US13/587,752 patent/US9089535B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011144201A5 (cg-RX-API-DMAC7.html) | ||
| He et al. | Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy | |
| Newman | Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases | |
| Kuzmov et al. | Nanotechnology approaches for inhalation treatment of lung diseases | |
| Virk et al. | Mast cells and their activation in lung disease | |
| JP2012503668A5 (cg-RX-API-DMAC7.html) | ||
| JP2013224331A5 (cg-RX-API-DMAC7.html) | ||
| CY1121090T1 (el) | Εισπνευσιμα σωματιδια που περιλαμβανουν τιοτροπιο | |
| MX377175B (es) | Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc). | |
| EA201201397A1 (ru) | Ингалятор, содержащий расслаиваемую блистерную упаковку | |
| IN2014DN08672A (cg-RX-API-DMAC7.html) | ||
| EP2682108A3 (en) | Dry Powder Inhalers Comprising a Carrier Other Than Lactose and a Ternary Component | |
| EA201201392A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
| EP2682097A3 (en) | Dry Powder Inhalers Comprising A Carrier Other Than Lactose | |
| CA2558212A1 (en) | Interferon-beta for anti-virus therapy for respiratory diseases | |
| JP2015511625A5 (cg-RX-API-DMAC7.html) | ||
| JP2007520507A5 (cg-RX-API-DMAC7.html) | ||
| EA201201395A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
| EA201201393A1 (ru) | Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка | |
| JP2014520874A5 (cg-RX-API-DMAC7.html) | ||
| EA201201389A1 (ru) | Ингалятор, создающий турбулентность | |
| ME02610B (me) | Aklidinijum za upotrebu u poboljšanju kvaliteta sna kod respiratornih pacijenata | |
| UA115989C2 (uk) | Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії | |
| JP2009514794A5 (cg-RX-API-DMAC7.html) | ||
| JP2015536334A5 (cg-RX-API-DMAC7.html) |